RadarFirst Unveils Radar AI Risk™, The Breakthrough Product Powering Next-Gen AI Compliance
The Elon Code Releases 2025 Transparency Update on Digital Cognitive Optimization
EXL announces availability of EXL Code Harbor™ and EXL Smart Agent Assist™ in the new AWS Marketplace AI Agents and Tools category
ASAPP’s GenerativeAgent Platform is Now Available in the New AWS Marketplace AI Agents and Tools Storefront
ARTICUL8 announces availability of LLM-IQ Evaluator and Network Topology Agents in the new AWS Marketplace AI Agents and Tools category
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
Company on track to initiate prophylactic study of PHVS416 ZUG, Switzerland, April 21, 2021 (GLOBE…
New combination trial of an RNA-targeted therapeutic candidate and an HBV immunotherapeutic candidate aimed at…
WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable…
WOBURN, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…
SAVE 1 to evaluate ATI-2173 in combination with tenofovir (TDF) vs. TDF plus placebo SAVE…
Mr. Rubin most recently served as Managing Director, Co-Head Life Sciences for Solebury Trout GAITHERSBURG,…
Cannabis industry leader to hold conference call on May 5 SALINAS, Calif., April 21, 2021…
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage…
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics, a company dedicated to unraveling…
WALTHAM, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage…
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial…
First-in-Class Bi-steric mTORC1 Inhibitor Advances into Clinical Development Newly Issued U.S. Patent Further Strengthens RMC-5552…
Expanding payment and communication options strengthens customer satisfaction and loyalty. FOLSOM, Calif., April 21, 2021…
PowerPlan announces newest SaaS solution: Workflow Process Automation ATLANTA, April 21, 2021 (GLOBE NEWSWIRE) —…
HOUSTON, April 21, 2021 (GLOBE NEWSWIRE) — Cardtronics announced today that Marqeta, the global modern…
ATLANTA, April 21, 2021 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it…